Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 30 | 2026 | 1020 | 4.310 |
Why?
|
| Heart Failure | 31 | 2026 | 2332 | 3.060 |
Why?
|
| Heart Transplantation | 22 | 2025 | 800 | 2.830 |
Why?
|
| Cardiomyopathies | 6 | 2023 | 514 | 1.110 |
Why?
|
| Heart Defects, Congenital | 12 | 2026 | 1889 | 1.070 |
Why?
|
| Ventricular Function, Left | 7 | 2022 | 549 | 0.970 |
Why?
|
| Pericarditis | 2 | 2023 | 45 | 0.740 |
Why?
|
| Child | 47 | 2026 | 26341 | 0.680 |
Why?
|
| Protein-Losing Enteropathies | 1 | 2018 | 19 | 0.570 |
Why?
|
| Overweight | 1 | 2021 | 387 | 0.570 |
Why?
|
| Heart Valve Diseases | 2 | 2021 | 162 | 0.560 |
Why?
|
| Myocarditis | 1 | 2019 | 122 | 0.520 |
Why?
|
| Retrospective Studies | 33 | 2025 | 17753 | 0.510 |
Why?
|
| Antineoplastic Agents | 3 | 2022 | 1826 | 0.500 |
Why?
|
| Cardiomyopathy, Dilated | 4 | 2025 | 187 | 0.480 |
Why?
|
| Fontan Procedure | 1 | 2018 | 180 | 0.480 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2015 | 21 | 0.450 |
Why?
|
| Prosthesis Failure | 1 | 2015 | 159 | 0.420 |
Why?
|
| Mitral Valve | 2 | 2018 | 247 | 0.420 |
Why?
|
| Cardiac Catheterization | 5 | 2025 | 630 | 0.420 |
Why?
|
| Humans | 59 | 2026 | 131163 | 0.390 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2018 | 425 | 0.360 |
Why?
|
| Registries | 5 | 2025 | 1634 | 0.360 |
Why?
|
| Treatment Outcome | 20 | 2025 | 12936 | 0.360 |
Why?
|
| Child, Preschool | 22 | 2026 | 15110 | 0.330 |
Why?
|
| Adolescent | 25 | 2026 | 20987 | 0.320 |
Why?
|
| Heart Failure, Systolic | 2 | 2021 | 35 | 0.310 |
Why?
|
| Echocardiography | 4 | 2025 | 1125 | 0.300 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2022 | 362 | 0.280 |
Why?
|
| Anemia, Iron-Deficiency | 2 | 2021 | 140 | 0.280 |
Why?
|
| Prosthesis Implantation | 2 | 2019 | 152 | 0.260 |
Why?
|
| Heart Ventricles | 2 | 2025 | 749 | 0.260 |
Why?
|
| Heart Atria | 2 | 2020 | 343 | 0.260 |
Why?
|
| Patient Selection | 2 | 2021 | 729 | 0.240 |
Why?
|
| Cancer Survivors | 2 | 2020 | 283 | 0.240 |
Why?
|
| Automobile Driving | 1 | 2026 | 29 | 0.230 |
Why?
|
| Male | 32 | 2026 | 64957 | 0.230 |
Why?
|
| Prosthesis Design | 5 | 2024 | 643 | 0.220 |
Why?
|
| Neoplasms | 4 | 2022 | 3016 | 0.220 |
Why?
|
| Shock, Cardiogenic | 2 | 2024 | 176 | 0.220 |
Why?
|
| Methylprednisolone | 1 | 2025 | 94 | 0.210 |
Why?
|
| Pacemaker, Artificial | 2 | 2025 | 193 | 0.210 |
Why?
|
| Atrioventricular Block | 1 | 2025 | 45 | 0.210 |
Why?
|
| Infant | 14 | 2026 | 13352 | 0.210 |
Why?
|
| Heart Diseases | 2 | 2020 | 499 | 0.210 |
Why?
|
| Ventricular Function, Right | 2 | 2025 | 126 | 0.190 |
Why?
|
| Cohort Studies | 6 | 2021 | 5063 | 0.190 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 2 | 2022 | 28 | 0.190 |
Why?
|
| Female | 29 | 2026 | 70963 | 0.190 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2025 | 301 | 0.180 |
Why?
|
| Pericardial Effusion | 1 | 2023 | 78 | 0.180 |
Why?
|
| Hemodynamics | 2 | 2025 | 810 | 0.170 |
Why?
|
| Glomerular Filtration Rate | 3 | 2021 | 566 | 0.170 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2022 | 77 | 0.170 |
Why?
|
| Thinness | 1 | 2021 | 71 | 0.170 |
Why?
|
| Graft Rejection | 3 | 2023 | 552 | 0.170 |
Why?
|
| Stroke Volume | 2 | 2022 | 541 | 0.170 |
Why?
|
| Cardiac Rehabilitation | 1 | 2021 | 29 | 0.170 |
Why?
|
| Transplant Recipients | 2 | 2020 | 235 | 0.170 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2022 | 70 | 0.170 |
Why?
|
| Feasibility Studies | 1 | 2024 | 824 | 0.170 |
Why?
|
| Transforming Growth Factor beta | 1 | 2023 | 451 | 0.170 |
Why?
|
| Connectin | 1 | 2020 | 30 | 0.160 |
Why?
|
| Hypertension, Pulmonary | 1 | 2025 | 457 | 0.160 |
Why?
|
| Anthracyclines | 1 | 2020 | 47 | 0.160 |
Why?
|
| Atrial Function, Left | 1 | 2020 | 37 | 0.160 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2020 | 45 | 0.160 |
Why?
|
| Developmental Disabilities | 1 | 2025 | 781 | 0.150 |
Why?
|
| Echocardiography, Doppler | 1 | 2020 | 158 | 0.150 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2020 | 123 | 0.150 |
Why?
|
| Device Removal | 2 | 2018 | 225 | 0.150 |
Why?
|
| Time Factors | 7 | 2025 | 6196 | 0.150 |
Why?
|
| Pulsatile Flow | 1 | 2019 | 110 | 0.150 |
Why?
|
| Diastole | 1 | 2020 | 181 | 0.150 |
Why?
|
| Adult | 12 | 2024 | 31282 | 0.150 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2019 | 18 | 0.150 |
Why?
|
| Radiation Injuries | 1 | 2020 | 141 | 0.140 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2019 | 77 | 0.140 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2025 | 629 | 0.140 |
Why?
|
| American Heart Association | 1 | 2021 | 343 | 0.140 |
Why?
|
| Consensus | 1 | 2021 | 512 | 0.140 |
Why?
|
| Acute Disease | 2 | 2019 | 1153 | 0.140 |
Why?
|
| Central Venous Pressure | 1 | 2018 | 25 | 0.140 |
Why?
|
| Cardiotonic Agents | 1 | 2019 | 138 | 0.140 |
Why?
|
| Vasodilator Agents | 1 | 2019 | 197 | 0.140 |
Why?
|
| Young Adult | 9 | 2024 | 10103 | 0.140 |
Why?
|
| Forecasting | 1 | 2019 | 351 | 0.140 |
Why?
|
| Tracheostomy | 1 | 2020 | 212 | 0.130 |
Why?
|
| Amino Acids | 1 | 2020 | 566 | 0.130 |
Why?
|
| Arterial Switch Operation | 1 | 2018 | 23 | 0.130 |
Why?
|
| Follow-Up Studies | 6 | 2025 | 5196 | 0.130 |
Why?
|
| Inflammation | 1 | 2025 | 1489 | 0.130 |
Why?
|
| Thrombosis | 1 | 2022 | 499 | 0.130 |
Why?
|
| Immunity, Humoral | 1 | 2018 | 74 | 0.130 |
Why?
|
| Patient Readmission | 1 | 2021 | 442 | 0.130 |
Why?
|
| Hospitals, Pediatric | 2 | 2021 | 808 | 0.130 |
Why?
|
| Patient Discharge | 1 | 2021 | 514 | 0.130 |
Why?
|
| Transposition of Great Vessels | 1 | 2018 | 118 | 0.120 |
Why?
|
| Creatinine | 1 | 2018 | 398 | 0.120 |
Why?
|
| Pulmonary Artery | 1 | 2019 | 434 | 0.120 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2018 | 178 | 0.120 |
Why?
|
| Kidney Transplantation | 1 | 2021 | 558 | 0.120 |
Why?
|
| Renal Insufficiency | 1 | 2018 | 259 | 0.120 |
Why?
|
| DNA-Binding Proteins | 1 | 2023 | 1939 | 0.110 |
Why?
|
| Stroke | 1 | 2023 | 1061 | 0.110 |
Why?
|
| Palliative Care | 1 | 2019 | 443 | 0.110 |
Why?
|
| Body Mass Index | 1 | 2021 | 1717 | 0.110 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2015 | 113 | 0.110 |
Why?
|
| Predictive Value of Tests | 4 | 2022 | 2304 | 0.110 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2015 | 246 | 0.100 |
Why?
|
| Kidney Failure, Chronic | 1 | 2021 | 934 | 0.100 |
Why?
|
| Heart Arrest | 1 | 2017 | 356 | 0.100 |
Why?
|
| Electrocardiography | 1 | 2019 | 970 | 0.100 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 1882 | 0.100 |
Why?
|
| Risk Factors | 7 | 2024 | 11074 | 0.100 |
Why?
|
| Hospital Mortality | 3 | 2024 | 1064 | 0.090 |
Why?
|
| Liver Transplantation | 1 | 2021 | 1147 | 0.090 |
Why?
|
| Miniaturization | 2 | 2024 | 26 | 0.090 |
Why?
|
| Signal Transduction | 1 | 2023 | 4686 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2019 | 3711 | 0.080 |
Why?
|
| Obesity | 1 | 2021 | 2426 | 0.080 |
Why?
|
| Prospective Studies | 4 | 2026 | 6459 | 0.080 |
Why?
|
| Graft Survival | 2 | 2021 | 465 | 0.070 |
Why?
|
| Ureteroscopes | 1 | 2008 | 1 | 0.070 |
Why?
|
| Cardiotoxicity | 2 | 2020 | 49 | 0.070 |
Why?
|
| Hospitalization | 3 | 2024 | 1950 | 0.070 |
Why?
|
| Equipment Design | 2 | 2026 | 512 | 0.070 |
Why?
|
| Infant, Newborn | 4 | 2023 | 8635 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2021 | 1071 | 0.060 |
Why?
|
| Incidence | 3 | 2018 | 3360 | 0.060 |
Why?
|
| United States | 4 | 2024 | 12072 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2017 | 3147 | 0.060 |
Why?
|
| Survival Rate | 2 | 2021 | 2114 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2019 | 1378 | 0.050 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2023 | 45 | 0.050 |
Why?
|
| Gene Knock-In Techniques | 1 | 2023 | 118 | 0.050 |
Why?
|
| Length of Stay | 2 | 2019 | 1421 | 0.050 |
Why?
|
| Age Factors | 2 | 2020 | 2825 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2020 | 3359 | 0.050 |
Why?
|
| Catheters | 1 | 2022 | 78 | 0.050 |
Why?
|
| Chlorides | 1 | 2022 | 97 | 0.050 |
Why?
|
| Hirudins | 1 | 2022 | 39 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2025 | 450 | 0.050 |
Why?
|
| Chest Pain | 1 | 2023 | 133 | 0.040 |
Why?
|
| Antithrombins | 1 | 2022 | 49 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 294 | 0.040 |
Why?
|
| Transferrin | 1 | 2021 | 46 | 0.040 |
Why?
|
| Diuretics | 1 | 2022 | 159 | 0.040 |
Why?
|
| Sodium | 1 | 2022 | 280 | 0.040 |
Why?
|
| Hemolysis | 1 | 2021 | 86 | 0.040 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2022 | 227 | 0.040 |
Why?
|
| North America | 1 | 2021 | 255 | 0.040 |
Why?
|
| Heparin | 1 | 2022 | 208 | 0.040 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2020 | 44 | 0.040 |
Why?
|
| Outpatients | 1 | 2022 | 262 | 0.040 |
Why?
|
| Exercise Test | 1 | 2021 | 239 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 214 | 0.040 |
Why?
|
| Systole | 1 | 2020 | 195 | 0.040 |
Why?
|
| Prognosis | 2 | 2019 | 4886 | 0.040 |
Why?
|
| Biopsy | 1 | 2023 | 1239 | 0.040 |
Why?
|
| Radiotherapy | 1 | 2020 | 119 | 0.040 |
Why?
|
| Desmoglein 2 | 1 | 2019 | 4 | 0.040 |
Why?
|
| Plakophilins | 1 | 2019 | 4 | 0.040 |
Why?
|
| Observer Variation | 1 | 2020 | 311 | 0.040 |
Why?
|
| Probability | 1 | 2019 | 306 | 0.040 |
Why?
|
| Bilirubin | 1 | 2019 | 126 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2020 | 307 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2022 | 1319 | 0.040 |
Why?
|
| Myocardium | 1 | 2023 | 852 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2022 | 482 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2022 | 687 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2022 | 487 | 0.040 |
Why?
|
| Unnecessary Procedures | 1 | 2019 | 61 | 0.040 |
Why?
|
| Iron | 1 | 2021 | 304 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 1490 | 0.030 |
Why?
|
| Aortic Valve | 1 | 2021 | 455 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2023 | 668 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2019 | 122 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2023 | 2885 | 0.030 |
Why?
|
| Exons | 1 | 2020 | 759 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2020 | 447 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 732 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2020 | 504 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2021 | 506 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 263 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2022 | 605 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2019 | 729 | 0.030 |
Why?
|
| Heart | 1 | 2022 | 650 | 0.030 |
Why?
|
| Apoptosis | 1 | 2023 | 1827 | 0.030 |
Why?
|
| Logistic Models | 1 | 2021 | 1797 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 1129 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2018 | 449 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2019 | 471 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2023 | 2465 | 0.030 |
Why?
|
| Respiration, Artificial | 1 | 2019 | 501 | 0.030 |
Why?
|
| Oxygen | 1 | 2019 | 548 | 0.030 |
Why?
|
| Middle Aged | 3 | 2024 | 28601 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2018 | 670 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 1410 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2020 | 562 | 0.030 |
Why?
|
| Pandemics | 1 | 2023 | 1118 | 0.030 |
Why?
|
| Reoperation | 1 | 2018 | 818 | 0.030 |
Why?
|
| Exome | 1 | 2019 | 1061 | 0.030 |
Why?
|
| Alleles | 1 | 2019 | 1673 | 0.030 |
Why?
|
| Recurrence | 1 | 2018 | 1489 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 2021 | 951 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2023 | 2406 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 2904 | 0.020 |
Why?
|
| Global Health | 1 | 2017 | 626 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2017 | 1240 | 0.020 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2019 | 682 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2019 | 1559 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2019 | 1106 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2019 | 844 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 3829 | 0.020 |
Why?
|
| Quality of Life | 1 | 2021 | 2082 | 0.020 |
Why?
|
| Texas | 1 | 2018 | 3686 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 3436 | 0.020 |
Why?
|
| Mice | 1 | 2023 | 18301 | 0.020 |
Why?
|
| Mutation | 1 | 2019 | 6099 | 0.010 |
Why?
|
| Animals | 1 | 2023 | 33912 | 0.010 |
Why?
|